There’s a new trend emerging in the diet and nutrition world, though those in the business will say they’ve been championing it for years. The hot tip for summer 2026? Eating.
The emaciated frames of a great number of women in the public eye might contradict this. Appetite-suppressing medications such as Ozempic, Wegovy and Mounjaro, brand-name medications which together are commonly known as GLP-1s, have been widely available for several years and celebrities from Sharon Osbourne to Serena Williams and Amy Schumer to Elon Musk have admitted to using these drugs. Wegovy (semaglutide) is the weight loss medication that emerged from Ozempic, which is prescribed for diabetes, while Mounjaro (tirzepatide) is a slightly different drug that works in the same way.
Nutritionist and bestselling author Dr Federica Amati has some advice for users – and for the rest of us. “Eat! Please eat! If you’re hungry, eat. Especially if you’re an older woman and you feel hungry, please eat.” Amati says that weight loss medication is dangerous when used as a quick-fix lifestyle intervention and that users are starving themselves of nutrients by eating too little, which can lead to medical malnutrition.
Amati works with women in their seventies and eighties in her clinical practice who are still concerned with losing weight even while they suffer with osteopenia, osteoporosis and perhaps have reduced mobility. As our bone density and ability to absorb nutrients decreases with age, older women have more reason than ever to eat well.
